Barrow Neurological Institute’s Ivy Brain Tumor Center Partners with Karyopharm Therapeutics

Barrow Neurological Institute’s Ivy Brain Tumor Center Partners with Karyopharm Therapeutics

Barrow Neurological Institute’s Ivy Brain Tumor Center has inked a partnership with Karyopharm Therapeutics (KPTI) to accelerate the treatment of brain cancer. The Ivy Brain Center will employ Karyopharm’s first-in-class oral Selective Inhibitor of Nuclear Export...

Pin It on Pinterest